Drug Shortage Report for FENTANYL CITRATE INJECTION, USP

Last updated on 2023-01-16 History
Report ID 170878
Drug Identification Number 02501554
Brand name FENTANYL CITRATE INJECTION, USP
Common or Proper name FENTANYL CITRATE INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) FENTANYL
Strength(s) 50MCG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR EPIDURAL
Packaging size 2mL
ATC code N01AH
ATC description ANESTHETICS, GENERAL
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-10-31
Actual start date
Estimated end date 2023-01-23
Actual end date 2023-01-13
Shortage status Resolved
Updated date 2023-01-16
Company comments Fresenius Kabi Canada regrets to advise that our available inventory of Fentanyl Citrate Injection, USP 50 mcg/mL 2 mL SD Vial is short dated. The current available inventory expires October 31, 2022. We will be facing a supply interruption as fresh inventory is expected to be available January 23, 2023. Please continue to order the short-dated product.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2023-01-16 French Compare
v6 2023-01-16 English Compare
v5 2022-11-11 French Compare
v4 2022-11-11 English Compare
v3 2022-11-01 English Compare
v2 2022-10-02 French Compare
v1 2022-10-02 English Compare

Showing 1 to 7 of 7